EGFR immunohistochemistry as biomarker for antibody-based therapy of squamous NSCLC – Experience from the first ring trial of the German Quality Assurance Initiative for Pathology (QuIP ® )

Author:

Petersen Iver,Dietel Manfred,Geilenkeuser Wolf J.,Mireskandari Masoud,Weichert Wilko,Steiger Katja,Scheel Andreas H.,Büttner Reinhard,Schirmacher Peter,Warth Arne,Lasitschka Felix,Schildhaus Hans-Ulrich,Kirchner Thomas,Reu Simone,Kreipe Hans,Länger Florian,Tiemann Markus,Schulte Christoph,Jöhrens Korinna

Funder

EGFR IHC lung SCC trial for providing feedback and information on technical details of their EGFR analysis

Publisher

Elsevier BV

Subject

Cell Biology,Pathology and Forensic Medicine

Reference33 articles.

1. Analytic variability in immunohistochemistry biomarker studies;Anagnostou;Cancer Epidemiol. Biomarkers Prev.,2010

2. Comparison of two antibodies for immunohistochemical evaluation of epidermal growth factor receptor expression in colorectal carcinomas, adenomas, and normal mucosa;Bhargava;Cancer,2006

3. Mammary tumorigenesis induced by fibroblast growth factor receptor 1 requires activation of the epidermal growth factor receptor;Bade;J. Cell Sci.,2011

4. EGFR-immunohistochemistry in colorectal cancer and non-small cell lung cancer: comparison of 3 commercially available EGFR-antibodies;Buffet;Acta Gastroenterol. Belg.,2008

5. Pharmacogenomics of EGFR-targeted therapies in non-small cell lung cancer: EGFR and beyond;Delaney;Chin. J. Cancer,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3